Evidence map›Paper›PMID 38226418›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2024

Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.

Nicolas Philip, Xin Yun, Hongyang Pi, Samuel Murray, Zack Hill, Jay Fonticella, Preston Perez, Cissy Zhang, Wimal Pathmasiri, Susan Sumner and 12 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Lipid Regulation of Mechanosensitive Ion Channels.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Transient Receptor Potential Vanilloid 4 (TRPV4) in the Human Carotid Body.International journal of molecular sciences · 2025
    Article
  9. Review
  10. Article
  11. Bioenergetics and metabolism of the pulmonary endothelium. Scientific session I: ReSPIRE 2025.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  12. Review
  13. Article
  14. Investigation of the molecular mechanism ofFrontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Nicolas PhilipDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Xin YunDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Hongyang PiDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, United States.
Samuel MurrayDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Zack HillDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Jay FonticellaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0001-9910-1933
Preston PerezDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Cissy ZhangGigantest, Inc., Baltimore, Maryland, United States.
Wimal PathmasiriDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States.
Susan SumnerDepartment of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States.
Laura ServinskyDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.ORCID 0009-0003-9863-9848
Haiyang JiangDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
John C HuetschDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
William M OldhamDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.ORCID 0000-0003-3029-4866
Scott VisovattiDepartment of Cardiology, Ohio State University School of Medicine, Columbus, Ohio, United States.
Peter J LearyDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, United States.
Sina A GharibDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, United States.ORCID 0000-0002-2480-4367
Evan BrittainDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States.
Catherine E SimpsonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0002-2388-5660
Anne LeGigantest, Inc., Baltimore, Maryland, United States.
Larissa A ShimodaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0001-5987-1378
Karthik SureshDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.ORCID 0000-0003-2920-0949
Johns Hopkins University · USUniversity of Washington · USUniversity of North Carolina at Chapel Hill · USBrigham and Women's Hospital · USThe Ohio State University · USVanderbilt University · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
National Metabolomics Data Repository - nextgen Metabolomics WorkbenchU2CDK119886 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2018 to 2021
$12.7M
Aquaporin 1 and pulmonary hypertensionR01HL126514 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHIMODA, LARISSA A. · 2015 to 2025
$4.5M
Biomedical Data Commons Workbench (BDCW)OT2OD030544 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANIAM, SHANKAR · 2020 to 2024
$3.2M
Metabolic regulation of Ca2+ entry and endothelial-mesenchymal transition in pulmonary arterial hypertensionR01HL151530 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SURESH, KARTHIK · 2021 to 2025
$2.0M
Web Portal CoreU2CDK119889 · NIDDK · UNIVERSITY OF FLORIDA · PI CONLON, MICHAEL, GARRETT, TIMOTHY J · 2018 to 2021
$1.9M
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsR01FD007627 · FDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AUSTIN, ERIC DOUGLAS, BRITTAIN, EVAN L · 2022 to 2025
$1.6M
The Pulmonary Hypertension- Multi-Dimensional Omics to Characterize Right Heart Adaptation (PH-MOCHA) studyR01HL152724 · NHLBI · UNIVERSITY OF WASHINGTON · PI GHARIB, SINA A, LEARY, PETER J · 2020 to 2023
$1.6M
The role of xanthine oxidoreductase activity and altered metabolism in scleroderma-associated pulmonary arterial hypertensionK23HL153781 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIMPSON, CATHERINE · 2020 to 2024
$883k
ROS-induced endothelial dysfunction in pulmonary arterial hypertensionK08HL132055 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SURESH, KARTHIK · 2017 to 2021
$828k
The Calpain/CaMKII/NHE Signaling Pathway in PAHK08HL133475 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HUETSCH, JOHN · 2016 to 2019
$687k
NHE1 signaling in Pulmonary Arterial HypertensionF32HL124727 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HUETSCH, JOHN · 2014 to 2015
$122k
HHS | National Institutes of Health (NIH) K08132055HHS | National Institutes of Health (NIH) K08HL133475HHS | National Institutes of Health (NIH) K23HL153781HHS | National Institutes of Health (NIH) R01HL126514HHS | National Institutes of Health (NIH) R01HL151530HHS | National Institutes of Health (NIH) R01HL152724NHLBI NIH HHS F32 HL124727NHLBI NIH HHS K08 HL132055NHLBI NIH HHS K08 HL133475NHLBI NIH HHS K23 HL153781NHLBI NIH HHS R01 HL126514NHLBI NIH HHS R01 HL151530NHLBI NIH HHS R01 HL152724NIDDK NIH HHS P30 DK056350NIDDK NIH HHS U2C DK119886NIDDK NIH HHS U2C DK119889NIH HHS OT2 OD030544
6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is a morbid disease characterized by significant lung endothelial cell (EC) dysfunction. Prior work has shown that microvascular endothelial cells (MVECs) isolated from animals with experimental PAH and patients with PAH exhibit significant abnormalities in metabolism and calcium signaling. With regards to metabolism, we and others have shown evidence of increased aerobic glycolysis and evidence of increased utilization of alternate fuel sources (such as fatty acids) in PAH EC. In the realm of calcium signaling, our prior work linked increased activity of the transient receptor potential vanilloid-4 (TRPV4) channel to increased proliferation of MVECs isolated from the Sugen/Hypoxia rat model of PAH (SuHx-MVECs). However, the relationship between metabolic shifts and calcium abnormalities was not clear. Specifically, whether shifts in metabolism were responsible for increasing TRPV4 channel activity in SuHx-MVECs was not known. In this study, using human data, serum samples from SuHx rats, and SuHx-MVECs, we describe the consequences of increased MVEC fatty acid oxidation in PAH. In human samples, we observed an increase in long-chain fatty acid levels that was associated with PAH severity. Next, using SuHx rats and SuHx-MVECs, we observed increased intracellular levels of lipids. We also show that increasing intracellular lipid content increases TRPV4 activity, whereas inhibiting fatty acid oxidation normalizes basal calcium levels in SuHx-MVECs. By exploring the fate of fatty acid-derived carbons, we observed that the metabolite linking increased intracellular lipids to TRPV4 activity was β-hydroxybutyrate (BOHB), a product of fatty acid oxidation. Finally, we show that BOHB supplementation alone is sufficient to sensitize the TRPV4 channel in rat and mouse MVECs. Returning to humans, we observe a transpulmonary BOHB gradient in human patients with PAH. Thus, we establish a link between fatty acid oxidation, BOHB production, and TRPV4 activity in MVECs in PAH. These data provide new insight into metabolic regulation of calcium signaling in lung MVECs in PAH.

Indexed as

Antineoplastic AgentsPulmonary Arterial HypertensionAnimalsCalciumEndothelial CellsFamilial Primary Pulmonary HypertensionFatty AcidsHumansLipidsLungMiceRatsTRPV Cation ChannelsAntineoplastic AgentsCalciumFatty AcidsLipidsTRPV4 protein, humanTrpv4 protein, mouseTrpv4 protein, ratTRPV Cation Channelscalciumendothelial cellsfatty acid oxidationmetabolismPAH

Identifiers

PMID38226418
PMCPMC11280685
OpenAlexW4390914323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.